CPT code 21014 represents the surgical excision of a soft tissue tumor on the face or scalp, a procedure performed to remove a lump or bump that is usually benign but excised for histopathologic evaluation to rule out cancer. This code matters nationally because facial and scalp soft tissue masses are common indications for outpatient surgical management and accurate coding supports appropriate coverage, payment, and tracking of oncologic evaluation pathways.

Key payers referenced include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context, typical sites of service, and common billing considerations for CPT code 21014. The publication summarizes payer coverage patterns and variations, benchmark payment information where available, and relevant policy or documentation priorities that affect claim adjudication. It also clarifies the clinical rationale for excision and laboratory submission for pathology.

This national-level summary is intended for billing professionals, practice managers, and clinicians seeking clear guidance on the clinical context and administrative implications of CPT code 21014. Data not available in the input is noted where applicable.